Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

SQZ Biotech

10 Disclosed Funding Rounds $226,415,000

0 Participating Investments


Therapeutics, Biotechnology, Life Science

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

Watertown, Massachusetts, United States, North America (US)

Organizations in Watertown in Therapeutics,
Organizations in Watertown in Biotechnology,
Organizations in Watertown in Life Science,
Organizations in Massachusetts in Therapeutics,
Organizations in Massachusetts in Biotechnology,
Organizations in Massachusetts in Life Science,
Organizations in United States in Therapeutics,
Organizations in United States in Biotechnology,
Organizations in United States in Life Science,
Organizations in North America in Therapeutics,
Organizations in North America in Biotechnology,
Organizations in North America in Life Science

Investors in Watertown in Therapeutics,
Investors in Watertown in Biotechnology,
Investors in Watertown in Life Science,
Investors in Massachusetts in Therapeutics,
Investors in Massachusetts in Biotechnology,
Investors in Massachusetts in Life Science,
Investors in United States in Therapeutics,
Investors in United States in Biotechnology,
Investors in United States in Life Science,
Investors in North America in Therapeutics,
Investors in North America in Biotechnology,
Investors in North America in Life Science

Greater Boston Area (0 Investors) (0 Startups), New England (0 Investors) (0 Startups), East Coast (0 Investors) (0 Startups), Northeastern US (0 Investors) (0 Startups)

Founded date 01, 2013

Founders Armon Sharei, Klavs Jensen, Robert Langer

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Equity

Also known as SQZ Biotechnologies

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that develops cellular therapies for multiple indications using the proprietary CellSqueeze technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.

Date Round Raised Lead
February, 12, 2021 Post-IPO Equity $60,000,000 -------
May, 18, 2020 Series D $65,000,000 Temasek Holdings
December, 06, 2019 Venture - Series Unknown $71,253,215 -------
August, 08, 2018 Series C $72,000,000 -------
December, 05, 2017 Venture - Series Unknown Undisclosed JDRF T1D Fund
December, 01, 2016 Series B $8,300,000 -------
September, 30, 2016 Series B $16,000,000 NanoDimension, Polaris Partners
June, 24, 2015 Series A $5,000,000 Polaris Partners
October, 29, 2014 Grant $100,000 -------
April, 07, 2014 Seed $15,000 -------

SQZ Biotech Investors (31)

Investor Lead? Round Participating Raise Date Partners
Illumina Ventures No Series D $65,000,000 May, 18, 2020 -------
Invus No Series D $65,000,000 May, 18, 2020 -------
Polaris Partners No Series D $65,000,000 May, 18, 2020 -------
JDRF T1D Fund No Series D $65,000,000 May, 18, 2020 -------
GV No Series D $65,000,000 May, 18, 2020 -------
NanoDimension No Series D $65,000,000 May, 18, 2020 -------
Temasek Holdings Yes Series D $65,000,000 May, 18, 2020 -------
Polaris Partners No Series C $72,000,000 August, 08, 2018 -------
Illumina Ventures No Series C $72,000,000 August, 08, 2018 -------
Total Access Fund No Series C $72,000,000 August, 08, 2018 -------
JDRF T1D Fund No Series C $72,000,000 August, 08, 2018 -------
Viva Ventures Biotech Fund No Series C $72,000,000 August, 08, 2018 -------
Alumni Ventures Group No Series C $72,000,000 August, 08, 2018 -------
GV No Series C $72,000,000 August, 08, 2018 -------
Global health sciences venture fund No Series C $72,000,000 August, 08, 2018 -------
Strawberry Creek Ventures No Series C $72,000,000 August, 08, 2018 -------
BRIDGE Healthcare Partners No Series C $72,000,000 August, 08, 2018 -------
Invus No Series C $72,000,000 August, 08, 2018 -------
Everblue Management No Series C $72,000,000 August, 08, 2018 -------
NanoDimension No Series C $72,000,000 August, 08, 2018 -------
Orient Life No Series C $72,000,000 August, 08, 2018 -------
Viva Ventures Biotech Fund No Series C $72,000,000 August, 08, 2018 -------
JMCR Partners No Series C $72,000,000 August, 08, 2018 -------
JDRF T1D Fund Yes Venture - Series Unknown Undisclosed December, 05, 2017 -------
Quark Venture No Series B $8,300,000 December, 01, 2016 -------
GV No Series B $8,300,000 December, 01, 2016 -------
NanoDimension Yes Series B $16,000,000 September, 30, 2016 -------
Polaris Partners Yes Series B $16,000,000 September, 30, 2016 -------
20/20 HealthCare Partners No Series A $5,000,000 June, 24, 2015 -------
Polaris Partners Yes Series A $5,000,000 June, 24, 2015 -------
MassChallenge No Grant $100,000 October, 29, 2014 -------